+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Vonvendi"

von Willebrand Disease (vWD) Market Opportunity Assessment, Epidemiology, Disease Management, Clinical Trials, Unmet Needs and Forecast to 2032 - Product Thumbnail Image

von Willebrand Disease (vWD) Market Opportunity Assessment, Epidemiology, Disease Management, Clinical Trials, Unmet Needs and Forecast to 2032

  • Report
  • July 2023
  • 57 Pages
  • Global
From
Von Willebrand Disease Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028) - Product Thumbnail Image

Von Willebrand Disease Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

  • Report
  • April 2023
  • 111 Pages
  • Global
From
Global VONVENDI Drug Market Report and Forecast 2023-2031 - Product Thumbnail Image

Global VONVENDI Drug Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 140 Pages
  • Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

The Vonvendi market is a segment of the hematological drugs market, which includes drugs used to treat blood-related diseases and disorders. These drugs are used to treat conditions such as anemia, hemophilia, and leukemia. Vonvendi is a brand of hematological drugs developed by the pharmaceutical company, Janssen Biotech. The Vonvendi market includes drugs that are used to treat a variety of blood-related diseases and disorders, including anemia, hemophilia, and leukemia. These drugs are designed to improve the quality of life of patients with these conditions. The Vonvendi market is highly competitive, with many pharmaceutical companies competing for market share. Some of the major players in the Vonvendi market include Janssen Biotech, Novartis, Pfizer, and Merck. Other companies in the market include AbbVie, Amgen, and Bristol-Myers Squibb. Show Less Read more